GLP-1 receptor agonist initiation and risk of psychiatric hospitalisation and emergency department presentation in adults with schizophrenia and type 2 diabetes in the USA: an observational cohort study using electronic health records data
https://t.co/Q6gCtrW3QD
@DrAsifQasim@RubenThurairaj This is what most short cases and PACES coaching is about familiarising doctors with cases that appear in exams. The GMC again demonstrates a biased @gmcuk to anything IMG. I am a bit surprised @bmj_latest report which could have been more balanced @KamranAbbasi
@DrDerekConnolly@DrDerekConnolly If the dose is decreased weight goes up but less than placebo. Important to set realistic targets and have patient on board to manage expectations
SURMOUNT-MAINTAIN answers the important question of “What happens when you stop a Mounjaro?” Which every patient wants to know….if you stop completely you will gain weight @EASDnews#EASD2026
📢 SAHF Poster Competition: Deadline 2 October!
There’s still time to submit your poster for the SAHF Poster Competition. Showcase your work at the SAHF Annual Conference and share your research with colleagues and delegates.
Submit by 2 October 2026.